Inhibition of neutrophil swarming by type I interferon promotes intracellular bacterial evasion.

Inhibition of neutrophil swarming by type I interferon promotes intracellular bacterial evasion.

Publication date: Oct 07, 2024

Listeria monocytogenes (LM) possesses the ability to breach multiple barriers and elicit intricate immune responses. However, there remains a lack of explicit understanding regarding how LM evades innate immune surveillance within the body. Here, we utilized liver intravital imaging to elucidate the dynamic process of LM during infection in the liver. We discovered that LM can rapidly escape from Kupffer cells (KCs) through listeriolysin O (LLO) and proliferate within hepatocytes. Upon LM exposure to the hepatic sinusoids, neutrophils rapidly aggregate at the site of infection. Subsequently, LM can induce type I interferon (IFN-I) production primarily in the spleen, which acts systemically on neutrophils to hamper their swarming by deactivating the ERK pathway, thus evading neutrophil-mediated eradication. Furthermore, our findings suggest that virus-induced IFN-I suppresses neutrophil swarming, and COVID-19 patients exhibit impaired neutrophil aggregation function. In conclusion, our findings provide compelling evidence demonstrating that intracellular bacteria represented by LM can hijack host defense mechanisms against viral infections to evade immune surveillance. Additionally, impaired neutrophil swarming caused by IFN-I is one of the significant factors contributing to the increased susceptibility to bacterial infections following viral infections.

Open Access PDF

Concepts Keywords
Bacterial Animals
Host Bacterial Toxins
Listeriolysin Bacterial Toxins
Liver COVID-19
Rapidly Female
Heat-Shock Proteins
Heat-Shock Proteins
Hemolysin Proteins
Hemolysin Proteins
Hepatocytes
Humans
Immune Evasion
Immunity, Innate
Interferon Type I
Interferon Type I
Kupffer Cells
Listeria monocytogenes
Listeriosis
Liver
Male
Mice
Neutrophils
SARS-CoV-2
Spleen

Semantics

Type Source Name
disease IDO process
disease MESH infection
disease IDO site of infection
disease IDO production
disease MESH COVID-19
disease IDO bacteria
disease IDO host
disease MESH viral infections
disease IDO susceptibility
disease MESH bacterial infections
disease IDO pathogen
pathway REACTOME Innate Immune System
disease IDO cell
pathway KEGG Phagosome
disease MESH death
pathway KEGG Lysosome
disease IDO infectivity
drug DRUGBANK Zileuton
disease IDO blood
drug DRUGBANK Oxygen
disease IDO replication
disease MESH Listeriosis

Original Article

(Visited 1 times, 1 visits today)